Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy

Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy

Therapy-resistant microenvironments represent a major barrier toward effective elimination of disseminated malignancies. Here, we show that select microenvironments can underlie resistance to antibody-based therapy. Using a humanized model of treatment refractory B cell leukemia, we find that infilt...

Full description

Bibliographic Details
Main Authors:	Pallasch, Christian, Leskov, Ilya B., Vorholt, Daniela, Drake, Adam, Bent, Eric H., Schwamb, Janine, Iliopoulou, Bettina P., Kutsch, Nadine, van Rooijen, Nico, Frenzel, Lukas P., Wendtner, Clemens M., Heukamp, Lukas, Kreuzer, Karl Anton, Hallek, Michael, Chen, Jianzhu, Braun, Christian Joerg, Soto Feliciano, Yadira Marie, Hemann, Michael
Other Authors:	Massachusetts Institute of Technology. Department of Biology
Format:	Article
Language:	en_US
Published:	Elsevier 2015
Online Access:	http://hdl.handle.net/1721.1/96265 https://orcid.org/0000-0001-5118-8478 https://orcid.org/0000-0002-5229-8748 https://orcid.org/0000-0002-5687-6154 https://orcid.org/0000-0002-6604-2129

Similar Items

Rapid generation of human B-cell lymphomas via combined expression of Myc and Bcl2 and their use as a preclinical model for biological therapies
by: Schweighofer, C. D., et al.
Published: (2014)

Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia
by: Carmen D. Herling, et al.
Published: (2018-02-01)

Unraveling Tumor Suppressor Networks with In Vivo RNAi
by: Braun, Christian Joerg, et al.
Published: (2015)

Human CD34+ CD133+ Hematopoietic Stem Cells Cultured with Growth Factors Including Angptl5 Efficiently Engraft Adult NOD-SCID Il2rγ−/− (NSG) Mice
by: Drake, Adam, et al.
Published: (2011)

A role for PVRL4-driven cell-cell interactions in tumorigenesis
by: Pallasch, Christian, et al.
Published: (2014)

Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
by: Nadine Kutsch, et al.
Published: (2022-06-01)

Mesenchymal stem cells secreting angiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potential
by: Drake, Adam, et al.
Published: (2012)

High variability of COVID-19 case fatality rate in Germany
by: Matthias Wjst, et al.
Published: (2023-03-01)

A role for PVRL4-driven cell–cell interactions in tumorigenesis
by: Natalya N Pavlova, et al.
Published: (2013-04-01)

Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing.
by: Claudia Vollbrecht, et al.
Published: (2015-01-01)

Macrophage-Mediated Antibody Dependent Effector Function in Aggressive B-Cell Lymphoma Treatment is Enhanced by Ibrutinib via Inhibition of JAK2
by: Verena Barbarino, et al.
Published: (2020-08-01)

Interleukins 7 and 15 Maintain Human T Cell Proliferative Capacity through STAT5 Signaling
by: Drake, Adam, et al.
Published: (2017)

Interleukins 7 and 15 Maintain Human T Cell Proliferative Capacity through STAT5 Signaling.
by: Adam Drake, et al.
Published: (2016-01-01)

The Future of Chronic Lymphocytic Leukemia Treatment- Balancing Efficacy, Safety and Cost
by: Valentin Goede, et al.
Published: (2013-10-01)

A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses
by: Bent, Eric H, et al.
Published: (2017)

Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis
by: Rike Schulte, et al.
Published: (2020-04-01)

Web-based database for the management of tissue specimens in a transregional histological research facility
by: Büttner Reinhard, et al.
Published: (2011-03-01)

Anti-proliferative effect of cytohesin inhibition in gefitinib-resistant lung cancer cells.
by: Anke Bill, et al.
Published: (2012-01-01)

Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
by: Othman Al-Sawaf, et al.
Published: (2023-10-01)

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia
by: Othman Al-Sawaf, et al.
Published: (2023-04-01)

Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG)
by: Nadine Kutsch, et al.
Published: (2020-02-01)

Versatile in vivo regulation of tumor phenotypes by dCas9-mediated transcriptional perturbation
by: Horlbeck, Max A., et al.
Published: (2018)

Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD
by: Nadine Kutsch, et al.
Published: (2022-07-01)

Towards control of chronic lymphocytic leukemia using chemotherapy-free combinations
by: Michael Hallek
Published: (2018-06-01)

Generative Design of the Architecture Platform in Multiprocessor System Design
by: Luise Müller, et al.
Published: (2024-04-01)

A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency
by: Hemann, Michael, et al.
Published: (2015)

Exploiting synthetic lethal interactions for targeted cancer therapy
by: Reinhardt, H. Christian, et al.
Published: (2012)

From Breaking Bad to Worse: Exploiting Homologous DNA Repair Deficiency in Cancer
by: Hemann, Michael
Published: (2015)

A Raf-competitive K-Ras binder can fail to functionally antagonize signaling
by: Kauke, Monique Jacqueline, et al.
Published: (2018)

Corrigendum: High-Protein Energy-Restriction: Effects on Body Composition, Contractile Properties, Mood, and Sleep in Active Young College Students
by: Christian Roth, et al.
Published: (2021-11-01)

High-Protein Energy-Restriction: Effects on Body Composition, Contractile Properties, Mood, and Sleep in Active Young College Students
by: Christian Roth, et al.
Published: (2021-06-01)

Universal mobile protection system for aerosol-generating medical interventions in COVID-19 patients
by: Florian Straube, et al.
Published: (2020-05-01)

Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
by: Nadine Kutsch, et al.
Published: (2022-04-01)

Heterotic bundles on Calabi-Yau manifolds with small Picard number
by: He, Y, et al.
Published: (2011)

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ
by: Floyd Hassenrück, et al.
Published: (2023-06-01)

Dashing Growth Curves: a web application for rapid and interactive analysis of microbial growth curves
by: Michael A. Reiter, et al.
Published: (2024-02-01)

Evaluation of the Prognostic Impact of SP263-Evaluated PD-L1 Expression in Patients with Stage III Non-Small Cell Lung Cancer (NSLC) Treated with Radio-Chemotherapy
by: Jan Nicolai Wagner, et al.
Published: (2024-03-01)

Inflammatory myofibroblastic tumour of the central airways: treatment and molecular analysis
by: Aparna Iyer, et al.
Published: (2021-03-01)

PHF6 is a novel regulator of B-cell identity in acute lymphoblastic leukemia
by: Soto-Feliciano, Yadira M. (Yadira Marie)
Published: (2016)

Antigen-Bearing Dendritic Cells Regulate the Diverse Pattern of Memory CD8 T Cell Development in Different Tissues
by: Shen, Ching-Hung, et al.
Published: (2011)